These data confirm that the Ldlr-/-.Leiden mouse model closely recapitulates the metabolic state of human NASH patients [20] and can therefore be used to evaluate the efficacy of therapeutic interventions. This evidence concerns the gene LDLR and metabolic dysfunction-associated steatohepatitis.